Review
doi: 10.1146/annurev.med.45.1.351.
Prostate carcinoma
Affiliations
- PMID: 7515219
- DOI: 10.1146/annurev.med.45.1.351
Item in Clipboard
Review
Prostate carcinoma
Annu Rev Med.
1994.
Abstract
Over the last several years, the development of prostate-specific antigen (PSA) testing and technical refinements of anatomic radical prostatectomy have revolutionized the care of patients with prostate cancer. Serum PSA testing often allows early diagnosis of organ-confined prostate cancer. Anatomical radical prostatectomy has a high probability of completely eradicating these tumors, with minimal long-term morbidity. Use of PSA testing after therapy confirms the long-term ability of surgery to eradicate early-stage prostate cancer.
Similar articles
-
[The value of PSA density for the diagnosis of prostatic cancer and for the indication of radical prostatectomy].Prog Urol. 1995 Apr;5(2):211-9, 220; discussion 219-20. Prog Urol. 1995. PMID: 7536529 French.
-
Prostate-specific antigen adjusted for total prostatic tumor volume as a predictor for outcome after radical prostatectomy.Prostate Cancer Prostatic Dis. 2007;10(1):60-5. doi: 10.1038/sj.pcan.4500902. Epub 2006 Oct 3. Prostate Cancer Prostatic Dis. 2007. PMID: 17003775
-
Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng./ml.J Urol. 2002 Jan;167(1):103-11. J Urol. 2002. PMID: 11743285
-
The risks outweigh the benefits of radical prostatectomy in localised prostate cancer: the argument for.Eur Urol. 1996;29 Suppl 2:27-30. doi: 10.1159/000473834. Eur Urol. 1996. PMID: 8717458 Review.
-
[Clinical surveillance after surgery for prostate cancer].Recenti Prog Med. 2003 Mar;94(3):110-3. Recenti Prog Med. 2003. PMID: 12677777 Review. Italian.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
